Addition of a carboxy terminal tail to the normally tailless gonadotropin-releasing hormone receptor impairs fertility in female mice

  1. Chirine Toufaily
  2. Jérôme Fortin
  3. Carlos AI Alonso
  4. Evelyne Lapointe
  5. Xiang Zhou
  6. Yorgui Santiago-Andres
  7. Yeu-Farn Lin
  8. Yiming Cui
  9. Ying Wang
  10. Dominic Devost
  11. Ferdinand Roelfsema
  12. Frederik Steyn
  13. Aylin C Hanyaloglu
  14. Terence E Hébert
  15. Tatiana Fiordelisio
  16. Derek Boerboom
  17. Daniel J Bernard  Is a corresponding author
  1. McGill University, Canada
  2. Universite de Montreal, Canada
  3. Universidad Nacional Autónoma de México, Mexico
  4. Leiden University Medical Center, Netherlands
  5. The University of Queensland, Australia
  6. Imperial College London, United Kingdom

Abstract

Gonadotropin-releasing hormone (GnRH) is the primary neuropeptide controlling reproduction in vertebrates. GnRH stimulates follicle-stimulating hormone (FSH) and luteinizing hormone (LH) synthesis via a G protein-coupled receptor, GnRHR, in the pituitary gland. In mammals, GnRHR lacks a C-terminal cytosolic tail (Ctail) and does not exhibit homologous desensitization. This might be an evolutionary adaptation that enables LH surge generation and ovulation. To test this idea, we fused the chicken GnRHR Ctail to the endogenous murine GnRHR in a transgenic model. The LH surge was blunted, but not blocked in these mice. In contrast, they showed reductions in FSH production, ovarian follicle development, and fertility. Addition of the Ctail altered the nature of agonist-induced calcium signaling required for normal FSH production. The loss of the GnRHR Ctail during mammalian evolution is unlikely to have conferred a selective advantage by enabling the LH surge. The adaptive significance of this specialization remains to be determined.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Chirine Toufaily

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. Jérôme Fortin

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Carlos AI Alonso

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Evelyne Lapointe

    Département de biomédecine vétérinaire, Universite de Montreal, Ste-Hyacinthe, Canada
    Competing interests
    The authors declare that no competing interests exist.
  5. Xiang Zhou

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Yorgui Santiago-Andres

    Departamento de Ecología y Recursos Naturales, Universidad Nacional Autónoma de México, Mexico City, Mexico
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7343-7746
  7. Yeu-Farn Lin

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Yiming Cui

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Ying Wang

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Dominic Devost

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. Ferdinand Roelfsema

    Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  12. Frederik Steyn

    School of Biomedical Sciences, The University of Queensland, Brisbane, Australia
    Competing interests
    The authors declare that no competing interests exist.
  13. Aylin C Hanyaloglu

    Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4206-737X
  14. Terence E Hébert

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  15. Tatiana Fiordelisio

    3epartamento de Ecología y Recursos Naturales, Universidad Nacional Autónoma de México, Mexico City, Mexico
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9282-1476
  16. Derek Boerboom

    Département de biomédecine vétérinaire, Universite de Montreal, Ste-Hyacinthe, Canada
    Competing interests
    The authors declare that no competing interests exist.
  17. Daniel J Bernard

    Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada
    For correspondence
    daniel.bernard@mcgill.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5365-5586

Funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mouse experiments in Canada were performed in accordance with institutional and federal guidelines and were approved by the McGill University Facility Animal Care Committee (DOW-A; protocol 5204). Mouse studies conducted at the National University of Mexico were performed under an institutional protocol similar to the United States Public Health Service Guide for the Care and Use of Laboratory Animals, and according to the Official Mexican Guide from the Secretary of Agriculture (SAGARPA NOM-062-Z00-1999).

Copyright

© 2021, Toufaily et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,016
    views
  • 153
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Chirine Toufaily
  2. Jérôme Fortin
  3. Carlos AI Alonso
  4. Evelyne Lapointe
  5. Xiang Zhou
  6. Yorgui Santiago-Andres
  7. Yeu-Farn Lin
  8. Yiming Cui
  9. Ying Wang
  10. Dominic Devost
  11. Ferdinand Roelfsema
  12. Frederik Steyn
  13. Aylin C Hanyaloglu
  14. Terence E Hébert
  15. Tatiana Fiordelisio
  16. Derek Boerboom
  17. Daniel J Bernard
(2021)
Addition of a carboxy terminal tail to the normally tailless gonadotropin-releasing hormone receptor impairs fertility in female mice
eLife 10:e72937.
https://doi.org/10.7554/eLife.72937

Share this article

https://doi.org/10.7554/eLife.72937

Further reading

    1. Cell Biology
    Dharmendra Kumar Nath, Subash Dhakal, Youngseok Lee
    Research Advance

    Understanding how the brain controls nutrient storage is pivotal. Transient receptor potential (TRP) channels are conserved from insects to humans. They serve in detecting environmental shifts and in acting as internal sensors. Previously, we demonstrated the role of TRPγ in nutrient-sensing behavior (Dhakal et al., 2022). Here, we found that a TRPγ mutant exhibited in Drosophila melanogaster is required for maintaining normal lipid and protein levels. In animals, lipogenesis and lipolysis control lipid levels in response to food availability. Lipids are mostly stored as triacylglycerol in the fat bodies (FBs) of D. melanogaster. Interestingly, trpγ deficient mutants exhibited elevated TAG levels and our genetic data indicated that Dh44 neurons are indispensable for normal lipid storage but not protein storage. The trpγ mutants also exhibited reduced starvation resistance, which was attributed to insufficient lipolysis in the FBs. This could be mitigated by administering lipase or metformin orally, indicating a potential treatment pathway. Gene expression analysis indicated that trpγ knockout downregulated brummer, a key lipolytic gene, resulting in chronic lipolytic deficits in the gut and other fat tissues. The study also highlighted the role of specific proteins, including neuropeptide DH44 and its receptor DH44R2 in lipid regulation. Our findings provide insight into the broader question of how the brain and gut regulate nutrient storage.

    1. Cell Biology
    2. Immunology and Inflammation
    Mykhailo Vladymyrov, Luca Marchetti ... Britta Engelhardt
    Tools and Resources

    The endothelial blood-brain barrier (BBB) strictly controls immune cell trafficking into the central nervous system (CNS). In neuroinflammatory diseases such as multiple sclerosis, this tight control is, however, disturbed, leading to immune cell infiltration into the CNS. The development of in vitro models of the BBB combined with microfluidic devices has advanced our understanding of the cellular and molecular mechanisms mediating the multistep T-cell extravasation across the BBB. A major bottleneck of these in vitro studies is the absence of a robust and automated pipeline suitable for analyzing and quantifying the sequential interaction steps of different immune cell subsets with the BBB under physiological flow in vitro. Here, we present the under-flow migration tracker (UFMTrack) framework for studying immune cell interactions with endothelial monolayers under physiological flow. We then showcase a pipeline built based on it to study the entire multistep extravasation cascade of immune cells across brain microvascular endothelial cells under physiological flow in vitro. UFMTrack achieves 90% track reconstruction efficiency and allows for scaling due to the reduction of the analysis cost and by eliminating experimenter bias. This allowed for an in-depth analysis of all behavioral regimes involved in the multistep immune cell extravasation cascade. The study summarizes how UFMTrack can be employed to delineate the interactions of CD4+ and CD8+ T cells with the BBB under physiological flow. We also demonstrate its applicability to the other BBB models, showcasing broader applicability of the developed framework to a range of immune cell-endothelial monolayer interaction studies. The UFMTrack framework along with the generated datasets is publicly available in the corresponding repositories.